Literature DB >> 20839717

Pain management in total joint arthroplasty: a historical review.

Terese T Horlocker1.   

Abstract

Patients undergoing total hip and knee arthroplasty experience substantial and sustained postoperative pain. Inadequate analgesia may impede recovery and delay hospital discharge. Traditionally, postoperative analgesia following arthroplasty was provided by intravenous patient-controlled analgesia or epidural analgesia, but each technique has distinct advantages and disadvantages. Recently, peripheral nerve blockade of the lumbosacral plexus has emerged as an alternative analgesic approach. An increasing number of studies have reported multimodal analgesia featuring unilateral peripheral block provide pain relief and functional outcomes similar to that of continuous epidural and superior to systemic analgesia but with fewer side effects. This review discusses the indications, benefits, and side effects associated with conventional and innovative analgesic approaches to facilitate rehabilitation and improve outcome following total joint arthroplasty. Copyright 2010, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20839717     DOI: 10.3928/01477447-20100722-65

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  26 in total

1.  CORR (®) Insights: Is Local Infiltration Analgesia Superior to Peripheral Nerve Blockade for Pain Management after THA: A Network Meta-analysis.

Authors:  Nikolaos V Bardakos
Journal:  Clin Orthop Relat Res       Date:  2015-12-16       Impact factor: 4.176

2.  Guest editorial: Perioperative pain management in orthopaedic surgery: editorial comment.

Authors:  Stavros G Memtsoudis
Journal:  Clin Orthop Relat Res       Date:  2014-05       Impact factor: 4.176

3.  Perioperative pregabalin does not reduce opioid requirements in total knee arthroplasty.

Authors:  Jing Hui Yik; Wei Yang Wilson Tham; Kwang Hui Tay; Liang Shen; Lingaraj Krishna
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-02-09       Impact factor: 4.342

4.  Continuous intraarticular and periarticular levobupivacaine for management of pain relief after total knee arthroplasty: A prospective randomized, double-blind pilot study.

Authors:  A Di Francesco; S Flamini; R Pizzoferrato; P Fusco; A Paglia
Journal:  J Orthop       Date:  2016-03-25

5.  Local infiltration analgesia adds no clinical benefit in pain control to peripheral nerve blocks after total knee arthroplasty.

Authors:  Pedro Hinarejos; Bruno Capurro; Xavier Santiveri; Pere Ortiz; Joan Leal; Xavier Pelfort; Raul Torres-Claramunt; Juan Sánchez-Soler; Joan C Monllau
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-06-14       Impact factor: 4.342

Review 6.  Current Approaches in Hip and Knee Arthroplasty Anaesthesia.

Authors:  Gülen Güler; Şebnem Atıcı; Ercan Kurt; Saffet Karaca; Aysun Yılmazlar
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-02-16

7.  Fewer postoperative fevers: an unexpected benefit of multimodal pain management?

Authors:  Joseph A Karam; Benjamin Zmistowski; Camilo Restrepo; William J Hozack; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2014-05       Impact factor: 4.176

8.  Can a periarticular levobupivacaine injection reduce postoperative opiate consumption during primary hip arthroplasty?

Authors:  Terence P Murphy; Damien P Byrne; Paul Curtin; Joseph F Baker; Kevin J Mulhall
Journal:  Clin Orthop Relat Res       Date:  2011-09-30       Impact factor: 4.176

9.  Receipt of Pain Management Information Preoperatively Is Associated With Improved Functional Gain After Elective Total Joint Arthroplasty.

Authors:  Celeste A Lemay; Courtland G Lewis; Jasvinder A Singh; Patricia D Franklin
Journal:  J Arthroplasty       Date:  2017-01-26       Impact factor: 4.757

10.  Capsaicin instillation for postoperative pain following total knee arthroplasty: a preliminary report of a randomized, double-blind, parallel-group, placebo-controlled, multicentre trial.

Authors:  Craig T Hartrick; Cecile Pestano; Nickole Carlson; Susan Hartrick
Journal:  Clin Drug Investig       Date:  2011-12-01       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.